Propiedad y actividad de insiders de IDEAYA Biosciences, Inc. (IDYA): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $37.73 |
| Capitalización | $3.6B |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $6.0M | $20.5M | $34.1M | $72.0M | $92.0M | $68.6M | $157.0M | $84.4M | $112.8M |
| Inversiones a Corto | $7.2M | $69.5M | $64.9M | $211.5M | $154.7M | $296.2M | $368.1M | $591.9M | $526.6M |
| Cuentas por Cobrar | 0 | 0 | 0 | $1.9M | $1.1M | $211000 | $18000 | $3000 | $6.0M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $13.6M | $90.7M | $101.7M | $288.6M | $251.0M | $370.5M | $532.6M | $689.7M | $666.7M |
| Inmovilizado Material | $3.7M | $5.2M | $9.7M | $9.5M | $8.7M | $9.0M | $8.4M | $27.7M | $31.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $17.5M | $96.5M | $113.0M | $298.3M | $381.3M | $388.0M | $649.3M | $1.12B | $1.11B |
| Cuentas por Pagar | $662000 | $1.4M | $709000 | $953000 | $2.1M | $4.3M | $6.6M | $15.4M | $17.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $339000 |
| Pasivos Corrientes | $2.4M | $5.4M | $6.9M | $38.6M | $45.2M | $31.7M | $27.1M | $46.1M | $58.8M |
| Deuda a Largo | $3.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $27.6M |
| Pasivos Totales | $33.2M | $145.5M | $12.6M | $100.0M | $79.8M | $38.5M | $28.2M | $64.9M | $86.4M |
| Reservas | -$16.2M | -$50.5M | -$92.5M | -$127.0M | -$176.7M | -$235.4M | -$348.4M | -$622.8M | -$736.5M |
| Patrimonio Neto | -$15.7M | -$48.9M | $100.4M | $198.3M | $301.5M | $349.5M | $621.1M | $1.06B | $1.02B |
| Deuda Total | $3.2M | 0 | $6.8M | $6.7M | $5.2M | $3.5M | $2.9M | $19.2M | $27.9M |
| Deuda Neta | -$9.9M | -$90.0M | -$92.2M | -$276.9M | -$241.6M | -$361.3M | -$522.2M | -$657.1M | -$611.5M |
| Capital Circulante | $11.1M | $85.3M | $94.7M | $250.0M | $205.8M | $338.7M | $505.5M | $643.6M | $607.9M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 10.45 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 20.70 |
Rentabilidad
| Rentabilidad sobre capital | -16.47% |
| Rentabilidad sobre capital invertido | -17.66% |
| Rentabilidad sobre activos | -13.36% |
| Margen bruto | -13.32% |
| Margen operativo | -92.66% |
| Margen neto | -74.75% |
Empresas relacionadas: ADPT · BEAM · CDTX · COGT · FOLD · KNSA · LEGN
Explorar sector: Healthcare · Biotechnology
Más secciones de IDYA: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones